- Home
- ATHA vs OP Comparison
ATHA vs OP Comparison
Compare ATHA & OP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- OP
- Stock Information
- Founded
- ATHA 2011
- OP 2021
- Country
- ATHA United States
- OP Greece
- Employees
- ATHA N/A
- OP N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- OP
- Sector
- ATHA Health Care
- OP
- Exchange
- ATHA Nasdaq
- OP Nasdaq
- Market Cap
- ATHA 14.8M
- OP 14.3M
- IPO Year
- ATHA 2020
- OP N/A
- Fundamental
- Price
- ATHA $0.36
- OP $1.24
- Analyst Decision
- ATHA Hold
- OP
- Analyst Count
- ATHA 3
- OP 0
- Target Price
- ATHA $0.50
- OP N/A
- AVG Volume (30 Days)
- ATHA 149.8K
- OP 1.2M
- Earning Date
- ATHA 11-06-2025
- OP 12-02-2025
- Dividend Yield
- ATHA N/A
- OP N/A
- EPS Growth
- ATHA N/A
- OP N/A
- EPS
- ATHA N/A
- OP N/A
- Revenue
- ATHA N/A
- OP $19,435,000.00
- Revenue This Year
- ATHA N/A
- OP N/A
- Revenue Next Year
- ATHA N/A
- OP N/A
- P/E Ratio
- ATHA N/A
- OP N/A
- Revenue Growth
- ATHA N/A
- OP N/A
- 52 Week Low
- ATHA $0.22
- OP $1.07
- 52 Week High
- ATHA $0.83
- OP $79.25
- Technical
- Relative Strength Index (RSI)
- ATHA 36.59
- OP 32.18
- Support Level
- ATHA $0.35
- OP $1.07
- Resistance Level
- ATHA $0.40
- OP $1.21
- Average True Range (ATR)
- ATHA 0.02
- OP 0.12
- MACD
- ATHA -0.00
- OP 0.76
- Stochastic Oscillator
- ATHA 11.86
- OP 25.37
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.
About OP OceanPal Inc.
OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary. The company includes Dry Bulk segment and Tanker segment. Majority of revenue is Dry Bulk segment.